Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

By Candiotti Keith A.   Gitlin Melvin C.  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1677-1684

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

By Imanaka Keiichiro   Tominaga Yushin   Etropolski Mila   van Hove Ilse   Ohsaka Masaki   Wanibe Mikio   Hirose Keiichiro   Matsumura Taka  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1399-1409

Informa Healthcare

Access to resources Recommend Favorite

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 20, Iss. 9, 2016-10 ,pp. : 1513-1518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 455-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Occupational Therapy Interventions in Chronic Pain – A Systematic Review

By  

OCCUPATIONAL THERAPY INTERNATIONAL, Vol. 22, Iss. 4, 2015-12 ,pp. : 183-194

John Wiley & Sons Inc

Access to resources Recommend Favorite